img

Global and United States Arthralgia Treatment Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and United States Arthralgia Treatment Market Report & Forecast 2024-2034

Arthralgia describes joint stiffness. Among its many causes are overuse, sprains, injury, gout, tendonitis and a number of infectious diseases, including rheumatic fever and chickenpox. Many people are becoming more aware of the importance of joint health and are taking proactive steps to manage joint pain. This includes regular exercise, a healthy diet, and the use of arthralgia management products such as supplements, pain relievers, and topical creams.
Market Analysis and InsightsGlobal and United States Arthralgia Treatment Market
This report focuses on global and United States Arthralgia Treatment market, also covers the segmentation data of other regions in regional level and county level.
The global Arthralgia Treatment revenue was US$ 5950 million in 2024 and is forecast to a readjusted size of US$ 10940 million by 2034 with a CAGR of 9.1% during the forecast period (2024-2034).
In United States the Arthralgia Treatment revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period (2024-2034).
The global key players of Arthralgia Treatment include Pfizer Inc., GSK Plc, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi S.A, Boehringer Ingelheim International GmbH, AstraZeneca and Johnson & Johnson Private Limited, etc. The global five biggest players hold a share of % in 2024.
Global Arthralgia Treatment Scope and Market Size
Arthralgia Treatment market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Arthralgia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2034.
For United States market, this report focuses on the Arthralgia Treatment market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in United States.



By Company


Pfizer Inc.
GSK Plc
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Sanofi S.A
Boehringer Ingelheim International GmbH
AstraZeneca
Johnson & Johnson Private Limited
Merck & Co., Inc.
Hoffmann-La Roche Ltd.
Bristol-Myers Squibb Company
Segment by Type
NSAID
Corticosteroids
Antidepressants
Anticonvulsants
Antibiotics

Segment by Application


Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Arthralgia Treatment definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Arthralgia Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Arthralgia Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Arthralgia Treatment sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion

Table of Content

1 Study Coverage
1.1 Arthralgia Treatment Product Introduction
1.2 Global Arthralgia Treatment Outlook 2018 VS 2024 VS 2034
1.2.1 Global Arthralgia Treatment Sales in US$ Million for the Year 2018-2034
1.2.2 Global Arthralgia Treatment Sales in Volume for the Year 2018-2034
1.3 United States Arthralgia Treatment Outlook 2018 VS 2024 VS 2034
1.3.1 United States Arthralgia Treatment Sales in US$ Million for the Year 2018-2034
1.3.2 United States Arthralgia Treatment Sales in Volume for the Year 2018-2034
1.4 Arthralgia Treatment Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.4.1 The Market Share of United States Arthralgia Treatment in Global, 2018 VS 2024 VS 2034
1.4.2 The Growth Rate of Arthralgia Treatment Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.5 Arthralgia Treatment Market Dynamics
1.5.1 Arthralgia Treatment Industry Trends
1.5.2 Arthralgia Treatment Market Drivers
1.5.3 Arthralgia Treatment Market Challenges
1.5.4 Arthralgia Treatment Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Arthralgia Treatment by Type
2.1 Arthralgia Treatment Market Segment by Type
2.1.1 NSAID
2.1.2 Corticosteroids
2.1.3 Antidepressants
2.1.4 Anticonvulsants
2.1.5 Antibiotics
2.2 Global Arthralgia Treatment Market Size by Type
2.2.1 Global Arthralgia Treatment Sales in Value, by Type (2018, 2024 & 2034)
2.2.2 Global Arthralgia Treatment Sales in Volume, by Type (2018, 2024 & 2034)
2.2.3 Global Arthralgia Treatment Average Selling Price (ASP) by Type (2018, 2024 & 2034)
2.3 United States Arthralgia Treatment Market Size by Type
2.3.1 United States Arthralgia Treatment Sales in Value, by Type (2018, 2024 & 2034)
2.3.2 United States Arthralgia Treatment Sales in Volume, by Type (2018, 2024 & 2034)
2.3.3 United States Arthralgia Treatment Average Selling Price (ASP) by Type (2018, 2024 & 2034)
3 Arthralgia Treatment by Application
3.1 Arthralgia Treatment Market Segment by Application
3.1.1 Hospital Pharmacy
3.1.2 Retail Pharmacy
3.1.3 Online Pharmacy
3.2 Global Arthralgia Treatment Market Size by Application
3.2.1 Global Arthralgia Treatment Sales in Value, by Application (2018, 2024 & 2034)
3.2.2 Global Arthralgia Treatment Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 Global Arthralgia Treatment Average Selling Price (ASP) by Application (2018, 2024 & 2034)
3.3 United States Arthralgia Treatment Market Size by Application
3.3.1 United States Arthralgia Treatment Sales in Value, by Application (2018, 2024 & 2034)
3.3.2 United States Arthralgia Treatment Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 United States Arthralgia Treatment Average Selling Price (ASP) by Application (2018, 2024 & 2034)
4 Global Arthralgia Treatment Competitor Landscape by Company
4.1 Global Arthralgia Treatment Market Size by Company
4.1.1 Global Key Manufacturers of Arthralgia Treatment, Ranked by Revenue (2024)
4.1.2 Global Arthralgia Treatment Revenue by Manufacturer (2018-2023)
4.1.3 Global Arthralgia Treatment Sales by Manufacturer (2018-2023)
4.1.4 Global Arthralgia Treatment Price by Manufacturer (2018-2023)
4.2 Global Arthralgia Treatment Concentration Ratio (CR)
4.2.1 Arthralgia Treatment Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Arthralgia Treatment in 2024
4.2.3 Global Arthralgia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Arthralgia Treatment, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Arthralgia Treatment, Product Offered and Application
4.5 Global Key Manufacturers of Arthralgia Treatment, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 United States Arthralgia Treatment Market Size by Company
4.7.1 Key Players of Arthralgia Treatment in United States, Ranked by Revenue (2024)
4.7.2 United States Arthralgia Treatment Revenue by Players (2018-2023)
4.7.3 United States Arthralgia Treatment Sales by Players (2018-2023)
5 Global Arthralgia Treatment Market Size by Region
5.1 Global Arthralgia Treatment Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Arthralgia Treatment Market Size in Volume by Region (2018-2034)
5.2.1 Global Arthralgia Treatment Sales in Volume by Region: 2018-2023
5.2.2 Global Arthralgia Treatment Sales in Volume Forecast by Region (2024-2034)
5.3 Global Arthralgia Treatment Market Size in Value by Region (2018-2034)
5.3.1 Global Arthralgia Treatment Sales in Value by Region: 2018-2023
5.3.2 Global Arthralgia Treatment Sales in Value by Region: 2024-2034
6 Americas
6.1 Americas Arthralgia Treatment Market Size YoY Growth 2018-2034
6.2 Americas Arthralgia Treatment Sales in Volume, by Type (2018, 2024 & 2034)
6.3 Americas Arthralgia Treatment Sales in Volume, by Application (2018, 2024 & 2034)
6.4 Americas Arthralgia Treatment Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 Americas Arthralgia Treatment Sales in Value by Country (2018, 2024 & 2034)
6.4.2 Americas Arthralgia Treatment Sales in Volume by Country (2018, 2024 & 2034)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Arthralgia Treatment Market Size YoY Growth 2018-2034
7.2 EMEA Arthralgia Treatment Sales in Volume, by Type (2018, 2024 & 2034)
7.3 EMEA Arthralgia Treatment Sales in Volume, by Application (2018, 2024 & 2034)
7.4 EMEA Arthralgia Treatment Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 EMEA Arthralgia Treatment Sales in Value by Country (2018, 2024 & 2034)
7.4.2 EMEA Arthralgia Treatment Sales in Volume by Country (2018, 2024 & 2034)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Arthralgia Treatment Market Size YoY Growth 2018-2034
8.2 China Arthralgia Treatment Sales in Volume, by Type (2018, 2024 & 2034)
8.3 China Arthralgia Treatment Sales in Volume, by Application (2018, 2024 & 2034)
9 APAC
9.1 APAC Arthralgia Treatment Market Size YoY Growth 2018-2034
9.2 APAC Arthralgia Treatment Sales in Volume, by Type (2018, 2024 & 2034)
9.3 APAC Arthralgia Treatment Sales in Volume, by Application (2018, 2024 & 2034)
9.4 APAC Arthralgia Treatment Market Facts & Figures by Region (2018, 2024 & 2034)
9.4.1 APAC Arthralgia Treatment Sales in Value by Region (2018, 2024 & 2034)
9.4.2 APAC Arthralgia Treatment Sales in Volume by Region (2018, 2024 & 2034)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Pfizer Inc.
10.1.1 Pfizer Inc. Company Information
10.1.2 Pfizer Inc. Description and Business Overview
10.1.3 Pfizer Inc. Arthralgia Treatment Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Inc. Arthralgia Treatment Products Offered
10.1.5 Pfizer Inc. Recent Development
10.2 GSK Plc
10.2.1 GSK Plc Company Information
10.2.2 GSK Plc Description and Business Overview
10.2.3 GSK Plc Arthralgia Treatment Sales, Revenue and Gross Margin (2018-2023)
10.2.4 GSK Plc Arthralgia Treatment Products Offered
10.2.5 GSK Plc Recent Development
10.3 Novartis AG
10.3.1 Novartis AG Company Information
10.3.2 Novartis AG Description and Business Overview
10.3.3 Novartis AG Arthralgia Treatment Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Novartis AG Arthralgia Treatment Products Offered
10.3.5 Novartis AG Recent Development
10.4 Mylan N.V.
10.4.1 Mylan N.V. Company Information
10.4.2 Mylan N.V. Description and Business Overview
10.4.3 Mylan N.V. Arthralgia Treatment Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Mylan N.V. Arthralgia Treatment Products Offered
10.4.5 Mylan N.V. Recent Development
10.5 Teva Pharmaceutical Industries Ltd.
10.5.1 Teva Pharmaceutical Industries Ltd. Company Information
10.5.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
10.5.3 Teva Pharmaceutical Industries Ltd. Arthralgia Treatment Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Teva Pharmaceutical Industries Ltd. Arthralgia Treatment Products Offered
10.5.5 Teva Pharmaceutical Industries Ltd. Recent Development
10.6 Sanofi S.A
10.6.1 Sanofi S.A Company Information
10.6.2 Sanofi S.A Description and Business Overview
10.6.3 Sanofi S.A Arthralgia Treatment Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Sanofi S.A Arthralgia Treatment Products Offered
10.6.5 Sanofi S.A Recent Development
10.7 Boehringer Ingelheim International GmbH
10.7.1 Boehringer Ingelheim International GmbH Company Information
10.7.2 Boehringer Ingelheim International GmbH Description and Business Overview
10.7.3 Boehringer Ingelheim International GmbH Arthralgia Treatment Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Boehringer Ingelheim International GmbH Arthralgia Treatment Products Offered
10.7.5 Boehringer Ingelheim International GmbH Recent Development
10.8 AstraZeneca
10.8.1 AstraZeneca Company Information
10.8.2 AstraZeneca Description and Business Overview
10.8.3 AstraZeneca Arthralgia Treatment Sales, Revenue and Gross Margin (2018-2023)
10.8.4 AstraZeneca Arthralgia Treatment Products Offered
10.8.5 AstraZeneca Recent Development
10.9 Johnson & Johnson Private Limited
10.9.1 Johnson & Johnson Private Limited Company Information
10.9.2 Johnson & Johnson Private Limited Description and Business Overview
10.9.3 Johnson & Johnson Private Limited Arthralgia Treatment Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Johnson & Johnson Private Limited Arthralgia Treatment Products Offered
10.9.5 Johnson & Johnson Private Limited Recent Development
10.10 Merck & Co., Inc.
10.10.1 Merck & Co., Inc. Company Information
10.10.2 Merck & Co., Inc. Description and Business Overview
10.10.3 Merck & Co., Inc. Arthralgia Treatment Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Merck & Co., Inc. Arthralgia Treatment Products Offered
10.10.5 Merck & Co., Inc. Recent Development
10.11 Hoffmann-La Roche Ltd.
10.11.1 Hoffmann-La Roche Ltd. Company Information
10.11.2 Hoffmann-La Roche Ltd. Description and Business Overview
10.11.3 Hoffmann-La Roche Ltd. Arthralgia Treatment Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Hoffmann-La Roche Ltd. Arthralgia Treatment Products Offered
10.11.5 Hoffmann-La Roche Ltd. Recent Development
10.12 Bristol-Myers Squibb Company
10.12.1 Bristol-Myers Squibb Company Company Information
10.12.2 Bristol-Myers Squibb Company Description and Business Overview
10.12.3 Bristol-Myers Squibb Company Arthralgia Treatment Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Bristol-Myers Squibb Company Arthralgia Treatment Products Offered
10.12.5 Bristol-Myers Squibb Company Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Arthralgia Treatment Industry Chain Analysis
11.2 Arthralgia Treatment Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Arthralgia Treatment Production Mode & Process
11.4 Arthralgia Treatment Sales and Marketing
11.4.1 Arthralgia Treatment Sales Channels
11.4.2 Arthralgia Treatment Distributors
11.5 Arthralgia Treatment Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Arthralgia Treatment CAGR in Value, United States VS Global, 2018 VS 2024 VS 2034
Table 2. Arthralgia Treatment Market Trends
Table 3. Arthralgia Treatment Market Drivers
Table 4. Arthralgia Treatment Market Challenges
Table 5. Arthralgia Treatment Market Restraints
Table 6. Global Arthralgia Treatment Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. United States Arthralgia Treatment Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Arthralgia Treatment Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. United States Arthralgia Treatment Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Manufacturers of Arthralgia Treatment, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Arthralgia Treatment Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Arthralgia Treatment Revenue Share by Manufacturer, 2018-2023
Table 13. Global Arthralgia Treatment Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global Arthralgia Treatment Sales Share by Manufacturer, 2018-2023
Table 15. Global Arthralgia Treatment Price by Manufacturer (2018-2023) & (US$/Unit)
Table 16. Global Arthralgia Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Arthralgia Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Arthralgia Treatment as of 2024)
Table 18. Global Key Manufacturers of Arthralgia Treatment, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Arthralgia Treatment, Product Offered and Application
Table 20. Global Key Manufacturers of Arthralgia Treatment, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Arthralgia Treatment in United States, Ranked by Revenue (2024) & (US$ million)
Table 23. United States Arthralgia Treatment Revenue by Players, (US$ Million), (2018-2023)
Table 24. United States Arthralgia Treatment Revenue Share by Players, (2018-2023)
Table 25. United States Arthralgia Treatment Sales by Players, (K Units), (2018-2023)
Table 26. United States Arthralgia Treatment Sales Share by Players, (2018-2023)
Table 27. Global Arthralgia Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 28. Global Arthralgia Treatment Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global Arthralgia Treatment Sales in Volume Forecast by Region (2024-2034) & (K Units)
Table 30. Global Arthralgia Treatment Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Arthralgia Treatment Sales in Value Forecast by Region (2024-2034) & (US$ Million)
Table 32. Americas Arthralgia Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. Americas Arthralgia Treatment Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Arthralgia Treatment Sales in Value by Country (2024-2034) & (US$ Million)
Table 35. Americas Arthralgia Treatment Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas Arthralgia Treatment Sales in Volume by Country (2024-2034) & (K Units)
Table 37. EMEA Arthralgia Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. EMEA Arthralgia Treatment Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Arthralgia Treatment Sales in Value by Country (2024-2034) & (US$ Million)
Table 40. EMEA Arthralgia Treatment Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA Arthralgia Treatment Sales in Volume by Country (2024-2034) & (K Units)
Table 42. APAC Arthralgia Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. APAC Arthralgia Treatment Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Arthralgia Treatment Sales in Value by Country (2024-2034) & (US$ Million)
Table 45. APAC Arthralgia Treatment Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC Arthralgia Treatment Sales in Volume by Country (2024-2034) & (K Units)
Table 47. Pfizer Inc. Company Information
Table 48. Pfizer Inc. Description and Business Overview
Table 49. Pfizer Inc. Arthralgia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 50. Pfizer Inc. Arthralgia Treatment Product
Table 51. Pfizer Inc. Recent Development
Table 52. GSK Plc Company Information
Table 53. GSK Plc Description and Business Overview
Table 54. GSK Plc Arthralgia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 55. GSK Plc Arthralgia Treatment Product
Table 56. GSK Plc Recent Development
Table 57. Novartis AG Company Information
Table 58. Novartis AG Description and Business Overview
Table 59. Novartis AG Arthralgia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 60. Novartis AG Arthralgia Treatment Product
Table 61. Novartis AG Recent Development
Table 62. Mylan N.V. Company Information
Table 63. Mylan N.V. Description and Business Overview
Table 64. Mylan N.V. Arthralgia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 65. Mylan N.V. Arthralgia Treatment Product
Table 66. Mylan N.V. Recent Development
Table 67. Teva Pharmaceutical Industries Ltd. Company Information
Table 68. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 69. Teva Pharmaceutical Industries Ltd. Arthralgia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 70. Teva Pharmaceutical Industries Ltd. Arthralgia Treatment Product
Table 71. Teva Pharmaceutical Industries Ltd. Recent Development
Table 72. Sanofi S.A Company Information
Table 73. Sanofi S.A Description and Business Overview
Table 74. Sanofi S.A Arthralgia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 75. Sanofi S.A Arthralgia Treatment Product
Table 76. Sanofi S.A Recent Development
Table 77. Boehringer Ingelheim International GmbH Company Information
Table 78. Boehringer Ingelheim International GmbH Description and Business Overview
Table 79. Boehringer Ingelheim International GmbH Arthralgia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 80. Boehringer Ingelheim International GmbH Arthralgia Treatment Product
Table 81. Boehringer Ingelheim International GmbH Recent Development
Table 82. AstraZeneca Company Information
Table 83. AstraZeneca Description and Business Overview
Table 84. AstraZeneca Arthralgia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. AstraZeneca Arthralgia Treatment Product
Table 86. AstraZeneca Recent Development
Table 87. Johnson & Johnson Private Limited Company Information
Table 88. Johnson & Johnson Private Limited Description and Business Overview
Table 89. Johnson & Johnson Private Limited Arthralgia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. Johnson & Johnson Private Limited Arthralgia Treatment Product
Table 91. Johnson & Johnson Private Limited Recent Development
Table 92. Merck & Co., Inc. Company Information
Table 93. Merck & Co., Inc. Description and Business Overview
Table 94. Merck & Co., Inc. Arthralgia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. Merck & Co., Inc. Arthralgia Treatment Product
Table 96. Merck & Co., Inc. Recent Development
Table 97. Hoffmann-La Roche Ltd. Company Information
Table 98. Hoffmann-La Roche Ltd. Description and Business Overview
Table 99. Hoffmann-La Roche Ltd. Arthralgia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. Hoffmann-La Roche Ltd. Arthralgia Treatment Product
Table 101. Hoffmann-La Roche Ltd. Recent Development
Table 102. Bristol-Myers Squibb Company Company Information
Table 103. Bristol-Myers Squibb Company Description and Business Overview
Table 104. Bristol-Myers Squibb Company Arthralgia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 105. Bristol-Myers Squibb Company Arthralgia Treatment Product
Table 106. Bristol-Myers Squibb Company Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Arthralgia Treatment Customers List
Table 110. Arthralgia Treatment Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Arthralgia Treatment Product Picture
Figure 2. Global Arthralgia Treatment Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Arthralgia Treatment Market Size 2018-2034 (US$ Million)
Figure 4. Global Arthralgia Treatment Sales 2018-2034 (K Units)
Figure 5. United States Arthralgia Treatment Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 6. United States Arthralgia Treatment Market Size 2018-2034 (US$ Million)
Figure 7. United States Arthralgia Treatment Sales 2018-2034 (K Units)
Figure 8. United States Arthralgia Treatment Market Share in Global, in Value (US$ Million) 2018-2034
Figure 9. United States Arthralgia Treatment Market Share in Global, in Volume (K Units) 2018-2034
Figure 10. Arthralgia Treatment Report Years Considered
Figure 11. Product Picture of NSAID
Figure 12. Product Picture of Corticosteroids
Figure 13. Product Picture of Antidepressants
Figure 14. Product Picture of Anticonvulsants
Figure 15. Product Picture of Antibiotics
Figure 16. Global Arthralgia Treatment Market Share by Type in 2024 & 2034
Figure 17. Global Arthralgia Treatment Sales in Value by Type (2018-2034) & (US$ Million)
Figure 18. Global Arthralgia Treatment Sales Market Share in Value by Type (2018-2034)
Figure 19. Global Arthralgia Treatment Sales by Type (2018-2034) & (K Units)
Figure 20. Global Arthralgia Treatment Sales Market Share in Volume by Type (2018-2034)
Figure 21. Global Arthralgia Treatment Price by Type (2018-2034) & (US$/Unit)
Figure 22. United States Arthralgia Treatment Market Share by Type in 2024 & 2034
Figure 23. United States Arthralgia Treatment Sales in Value by Type (2018-2034) & (US$ Million)
Figure 24. United States Arthralgia Treatment Sales Market Share in Value by Type (2018-2034)
Figure 25. United States Arthralgia Treatment Sales by Type (2018-2034) & (K Units)
Figure 26. United States Arthralgia Treatment Sales Market Share in Volume by Type (2018-2034)
Figure 27. United States Arthralgia Treatment Price by Type (2018-2034) & (US$/Unit)
Figure 28. Product Picture of Hospital Pharmacy
Figure 29. Product Picture of Retail Pharmacy
Figure 30. Product Picture of Online Pharmacy
Figure 31. Global Arthralgia Treatment Market Share by Application in 2024 & 2034
Figure 32. Global Arthralgia Treatment Sales in Value by Application (2018-2034) & (US$ Million)
Figure 33. Global Arthralgia Treatment Sales Market Share in Value by Application (2018-2034)
Figure 34. Global Arthralgia Treatment Sales by Application (2018-2034) & (K Units)
Figure 35. Global Arthralgia Treatment Sales Market Share in Volume by Application (2018-2034)
Figure 36. Global Arthralgia Treatment Price by Application (2018-2034) & (US$/Unit)
Figure 37. United States Arthralgia Treatment Market Share by Application in 2024 & 2034
Figure 38. United States Arthralgia Treatment Sales in Value by Application (2018-2034) & (US$ Million)
Figure 39. United States Arthralgia Treatment Sales Market Share in Value by Application (2018-2034)
Figure 40. United States Arthralgia Treatment Sales by Application (2018-2034) & (K Units)
Figure 41. United States Arthralgia Treatment Sales Market Share in Volume by Application (2018-2034)
Figure 42. United States Arthralgia Treatment Price by Application (2018-2034) & (US$/Unit)
Figure 43. Americas Arthralgia Treatment Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 44. Americas Arthralgia Treatment Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 45. Americas Arthralgia Treatment Sales by Type (2018-2034) & (K Units)
Figure 46. Americas Arthralgia Treatment Sales Market Share in Volume by Type (2018-2034)
Figure 47. Americas Arthralgia Treatment Sales by Application (2018-2034) & (K Units)
Figure 48. Americas Arthralgia Treatment Sales Market Share in Volume by Application (2018-2034)
Figure 49. United States Arthralgia Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 50. Canada Arthralgia Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 51. Mexico Arthralgia Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 52. Brazil Arthralgia Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 53. EMEA Arthralgia Treatment Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 54. EMEA Arthralgia Treatment Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 55. EMEA Arthralgia Treatment Sales by Type (2018-2034) & (K Units)
Figure 56. EMEA Arthralgia Treatment Sales Market Share in Volume by Type (2018-2034)
Figure 57. EMEA Arthralgia Treatment Sales by Application (2018-2034) & (K Units)
Figure 58. EMEA Arthralgia Treatment Sales Market Share in Volume by Application (2018-2034)
Figure 59. Europe Arthralgia Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 60. Middle East Arthralgia Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 61. Africa Arthralgia Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 62. China Arthralgia Treatment Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 63. China Arthralgia Treatment Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 64. China Arthralgia Treatment Sales by Type (2018-2034) & (K Units)
Figure 65. China Arthralgia Treatment Sales Market Share in Volume by Type (2018-2034)
Figure 66. China Arthralgia Treatment Sales by Application (2018-2034) & (K Units)
Figure 67. China Arthralgia Treatment Sales Market Share in Volume by Application (2018-2034)
Figure 68. APAC Arthralgia Treatment Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 69. APAC Arthralgia Treatment Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 70. APAC Arthralgia Treatment Sales by Type (2018-2034) & (K Units)
Figure 71. APAC Arthralgia Treatment Sales Market Share in Volume by Type (2018-2034)
Figure 72. APAC Arthralgia Treatment Sales by Application (2018-2034) & (K Units)
Figure 73. APAC Arthralgia Treatment Sales Market Share in Volume by Application (2018-2034)
Figure 74. Japan Arthralgia Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 75. South Korea Arthralgia Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 76. China Taiwan Arthralgia Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 77. Southeast Asia Arthralgia Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 78. India Arthralgia Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 79. Arthralgia Treatment Value Chain
Figure 80. Arthralgia Treatment Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed